Investigador Centro o unidad
de investigación		 Publicaciones Líneas de
investigación

Dr. Escobedo de la Peña J.

UIEC DR. CARLOS MAC GREGOR SÁNCHEZ NAVARRO

Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study.

Cardiovascular Diseases

Clinical Trials as Topic

Diabetes Mellitus, Type 2

Ver (8) más

Dr. De la Cruz Villegas M.

UIM ENFERMEDADES INFECCIOSAS Y PARASITARIAS

cAMP Receptor Protein Positively Regulates the Expression of Genes Involved in the Biosynthesis of Klebsiella oxytoca Tilivalline Cytotoxin

Klebsiella pneumoniae

Salmonella Infections

Helicobacter pylori

Ver (3) más

Dra. Hernández Flores G.

CIB OCCIDENTE

Apoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancer.

Sin lineas registradas.

Dr. Guzmán de la Garza F.

UIE Y SERVICIOS DE SALUD MONTERREY

Bupropion reduces the inflammatory response and intestinal injury due to ischemia-reperfusion.

Anthropometry

Physiology

Dra. Jáuregui Renaud K.

UIM OTONEUROLOGÍA

Comparative study of cerebral blood flow between postural tachycardia and neurocardiogenic syncope, during head-up tilt test.

Occupational Stress

Autonomic Nervous System

Gait

Ver (3) más

Dr. Jiménez Ferrer J.

CIB SUR

Micropropagation of lepidium virginicum (Brassicaceae), a plant with antiprotozoal activity

Antidepressive Agents

Antihypertensive Agents

Kidney Diseases

Ver (3) más

Dra. Fuentes Orozco C.

UIEC GUADALAJARA

First Steps of the Mexico Twin Registry (RGMex-MexTR) at the University of Guadalajara.

Fibrin

Glutamine

Indomethacin

Dr. Guerrero Romero J.

UIEC DURANGO

Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus.

Diabetes Mellitus, Type 2

Insulin Resistance

Magnesium

Ver (7) más

Dr. Salcedo Vargas M.

UIM ENFERMEDADES ONCOLÓGICAS

The role of developmental HOX genes in cervical cancer.

Proteogenomics

Integrative Oncology

Genetic Markers

Ver (9) más

Dr. Guerrero Romero J.

UIEC DURANGO

Associated Risk Factors for Latent Tuberculosis Infection in Subjects with Diabetes

Diabetes Mellitus, Type 2

Insulin Resistance

Magnesium

Ver (7) más

Dra. Peñuelas Urquides K.

CIB NORESTE

Association between genetic variations at 8q24 and prostate cancer risk in Mexican Men

Antibiotics, Antitubercular

Antitubercular Agents

Mycobacterium tuberculosis

Ver (3) más

Dra. Basurto Acevedo M.

UIM ENFERMEDADES ENDÓCRINAS

Efecto clínico de las diferentes vías de la terapia de reemplazo hormonal

Endocrine System Diseases

Metabolic Diseases

Obesity

Ver (1) más

Dra. Basurto Acevedo M.

UIM ENFERMEDADES ENDÓCRINAS

Circulating levels of plasminogen activator inhibitor-1 are associated with metabolic syndrome rather than with menopause.

Endocrine System Diseases

Metabolic Diseases

Obesity

Ver (1) más

Dra. Jiménez Arellanes M.

UIM FARMACOLOGÍA

CLINICAL STUDIES OF SILYMARIN AS A PROTECTIVE AGENT AGAINST LIVER DAMAGE CAUSED BY ANTI-TB DRUGS, METHOTREXATE, AND IN CASES OF CHRONIC HEPATITIS C AND DIABETES MELLITUS

Anti-Inflammatory Agents, Non-Steroidal

Antibiotics, Antitubercular

Arthritis, Experimental

Ver (5) más

Dra. Ordoñez Razo R.

UIM GENÉTICA HUMANA

Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis.

Breast Diseases

Cardiomyopathy, Hypertrophic

Developmental Disabilities

Ver (5) más

Dra. Sánchez López J.

CIB OCCIDENTE

Medium and large alleles of the PGC gene are risk factors for gastric cancer

Breast Neoplasms

Precancerous Conditions

Stomach Neoplasms

Ver (1) más

Dra. Camacho Moll M.

CIB NORESTE

Expression of Intermediate Filaments in the Developing Testis and Testicular Germ Cell Cancer

Urinary Bladder Neoplasms

Data Interpretation, Statistical

Epidemiology

Ver (8) más

Mtra. Albarran Sanchez A.

UIM ENFERMEDADES ENDÓCRINAS

Real-world evidence of the use of glucocorticoids for severe COVID-19

Diabetes Mellitus

Mucormycosis

Obesity

Ver (2) más

Dr. Jave Suárez L.

CIB OCCIDENTE

On the Regulation of NF-κB Pathway by HPV Oncoproteins: Are Pathway Inhibitors a Good Alternative for the Treatment of Cervical Cancer?

Breast Neoplasms

Uterine Cervical Dysplasia

Leukemia

Ver (2) más

Dra. Aguilar Lemarroy A.

CIB OCCIDENTE

Differential sensitivity of human papillomavirus type 16(+) and type 18(+) cervical carcinoma cells to CD95-mediated apoptosis.

Sin lineas registradas.